nicotinamide mononucleotide has been researched along with lycopene in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dilxat, T; Lin, J; Liu, X; Qiu, T; Shi, Q | 1 |
1 other study(ies) available for nicotinamide mononucleotide and lycopene
| Article | Year |
|---|---|
The combination of nicotinamide mononucleotide and lycopene prevents cognitive impairment and attenuates oxidative damage in D-galactose induced aging models via Keap1-Nrf2 signaling.
Topics: Aging; Animals; Cognitive Dysfunction; Drug Therapy, Combination; Galactose; Gene Expression Regulation; Kelch-Like ECH-Associated Protein 1; Lycopene; Male; Morris Water Maze Test; NF-E2-Related Factor 2; Nicotinamide Mononucleotide; Oxidative Stress; PC12 Cells; Rats; Signal Transduction; Spatial Learning; Treatment Outcome | 2022 |